Akira Horiuchi

16PUBLICATIONS
19CO-AUTHORS
Epidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Mechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 07, 2026
Five-Year Unified Risk Prediction Model for Gastric and Esophageal Cancer Based on Nationwide Health Check-Up Data in Japan: J-GESS Score.

|May 02, 2026
Selective IL-23 inhibitors in ulcerative colitis: current evidence and perspectives for multimodal personalized treatment: a narrative review.

|Apr 29, 2026
Frailty and geriatric complications in older patients with IBD: a nationwide hospital claims database study across Japan.

|Mar 06, 2026
Histopathological predictor of response to mirikizumab in active ulcerative colitis.

Ichitaro Horiuchi, Akira Horiuchi, Kaori Horiuchi

|Oct 29, 2025
Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis.

Ichitaro Horiuchi, Akira Horiuchi, Kaori Horiuchi

|Aug 14, 2025
Assessment of Ulcerative Colitis Patients with Elevated Neutrophilic Infiltration in the Colonic Mucosal Epithelium Using the Komagane Subclassification of the Geboes Score Grade 3.

Satoshi Ukai, Ichitaro Horiuchi, Tsuyoshi Terashima

Pageof 3

Frequent Collaborators

2 joint publications

Takahiro Kudo

2 joint publications

Takeji Umemura

1 joint publications

Yoshiko Nakayama

1 joint publications

Yozo Nakazawa